{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-011542","form_type":"8-K","ticker":"AZTA","cik":"0000933974","company_name":"Azenta, Inc.","filed_at":"2026-04-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.951752+00:00","generated_at":"2026-05-15T07:12:17.003505+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Azenta appoints Trey Martin as Multiomics President; Ginger Zhou steps down","bullets":["Trey Martin appointed President of Multiomics effective April 6, 2026; reports to CEO John Marotta.","Martin most recently served as CEO of Maravai LifeSciences (MRVI) and previously led IDT under Danaher (DHR).","Ginger Zhou stepped down as President; she will remain as advisor through November 2026 under a consulting agreement with $103,500 initial fee.","Executive officers Lawrence Lin, Ephraim Starr, and Olga Pirogova received amended offer letters clarifying severance and change-in-control terms.","Azenta aims to accelerate Multiomics long-range plan focusing on global synthesis scale, operational excellence, and profitable growth."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-011542","json":"https://secwatch.observer/filing/0001437749-26-011542.json","markdown":"https://secwatch.observer/filing/0001437749-26-011542.md","text":"https://secwatch.observer/filing/0001437749-26-011542.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/933974/000143774926011542/0001437749-26-011542-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/933974/000143774926011542/azta20260407_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T07:12:17.003505+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}